Cyonse

Cyonse Capsule 1Mg

Tacrolimus

BIOCARE PHARMACEUTICAL

Drug Identity

Active Ingredient
Tacrolimus
Drug Class
Immunosuppressants
ATC Code
D11AH01, L04AD02
Status
Essential Medicine

How to Take It

Dosage information not available for this product.

Safety Alerts

Avoid concurrent administration with ciclosporin (care if patient has previously received ciclosporin)

Important Warnings

Increased risk of infections, lymphoproliferative disorders, malignancies, neurotoxicity, QT-interval prolongation, UV light (avoid excessive exposure to sunlight and sunlamps)
Cardiomyopathy has been reported in children given tacrolimus after transplantation
Patients should be monitored carefully by echocardiography for hypertrophic changes
dose reduction or discontinuation should be considered if these occur
Monitor visual status, blood glucose, haematological and neurological parameters and whole blood 'trough' concentrations of tacrolimus (especially during episodes of diarrhoea), may affect performance of skilled tasks (e

Side Effects

Alopeciaanaemiaanorexiaanxietyarthralgiaascitesbile-duct abnormalitiesblood disorderscholestasisconvulsionconfusiondepressiondizzinessdyspneaelectrolyte disturbances

Price Intelligence

Rs 10,508.8
DRAP approved maximum price · per pack of 50 · approved 23 Jul, 2026
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
No retail prices recorded

Should you consider an alternative?

Other options containing Tacrolimus, and what they are not.

For pharma professionalsCompany, market and opportunity intelligence

Company

26
brands
30
molecules
1
alerts

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.